Volume 20 No 12 (2022)
 Download PDF
Overview of regulatory systems and technology for tracking counterfeit, adulterated and sub-stranded medications with the recommendation in Indian regulatory systems
Jyothika Thuyamani, Raju Kamaraj
Drugs maintain wellness, prevent illness, treat disease, stop epidemics, and save lives. Fake, adulterated, and substandard medications are the main obstacle to this goal. Falsified drugs contain unclean, filthy, or rotting substances. In India, medication is "Not of Standard Quality" if it doesn't meet requirements. Fake or counterfeit pharmaceuticals threaten the industry's reputation and public health. Anyone promoting Substandard/ Spurious/ Falsely-labelled/ Falsified/ Counterfeit Medical Products on the market can have their licence suspended. Mashelkar Committee suggests regulatory frameworks to eliminate fake and inferior medications. The committee considers amending the Drugs and Cosmetics Act to punish fake drug sellers. The government has changed how whistleblowers are rewarded. This initiative includes informants and officials. Several anticounterfeit medicine technologies can track real and fake drugs. The Broadband Acoustic Resonance Dissolution Spectroscopy test uses a dissolution-based method to identify fake and real medication products using an audio spectrum.
Spurious drug, Sub-stranded, Counterfeit, Adulterated, Falsified
Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.